GO:0032079 positive regulation of endodeoxyribonuclease activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0032079 describes any process that activates or increases the frequency, rate or extent of endodeoxyribonuclease activity, which creates internal breaks in DNA.
• Endodeoxyribonucleases are essential for meiotic recombination, DNA repair, and programmed cell death, and their positive regulators include the FIGNL1-FIRRM complex and chromatin remodellers.
• The term is a biological process child of positive regulation of nuclease activity and is distinct from endodeoxyribonuclease activity itself (GO:0004520).
• Dysregulation of endodeoxyribonuclease positive regulation is linked to cancer, neurodegeneration, and developmental disorders.
• CRISPR knockout, point mutation, knock-in, and overexpression models are key tools to dissect the regulatory network of GO:0032079.
• High-throughput screens and bioinformatics analyses are increasingly used to identify upstream regulators of endodeoxyribonuclease activity.
Description
Endodeoxyribonucleases are enzymes that hydrolyze internal phosphodiester bonds in DNA, generating breaks that are critical for DNA repair, recombination, and apoptosis. The activity of these enzymes must be tightly controlled to avoid genomic instability. GO:0032079, positive regulation of endodeoxyribonuclease activity, encompasses any process that activates or increases the frequency, rate or extent of such endonucleolytic cleavage. This regulation is vital for meiotic recombination, where the FIGNL1-FIRRM complex prevents DNA damage-independent loading of RAD51 and DMC1, thereby ensuring proper endodeoxyribonuclease function. In addition, chromatin remodellers such as BRG1 act as activators of transcription and can influence the expression of genes involved in DNA metabolism, indirectly affecting endodeoxyribonuclease activity. Understanding the positive regulation of endodeoxyribonuclease activity is therefore central to deciphering mechanisms of genome maintenance and cell fate decisions.
positive regulation of endodeoxyribonuclease activity At A Glance
| GO ID | GO:0032079 |
|---|---|
| GO term | positive regulation of endodeoxyribonuclease activity |
| Ontology | biological_process |
| Synonym | activation of endodeoxyribonuclease activity; endodeoxyribonuclease activator; stimulation of endodeoxyribonuclease activity; up regulation of endodeoxyribonuclease activity; up-regulation of endodeoxyribonuclease activity; upregulation of endodeoxyribonuclease activity |
| Major function | Activates or increases the rate of internal DNA cleavage by endodeoxyribonucleases |
| Parent term | positive regulation of nuclease activity (GO:0032078) |
| Related molecular function | endodeoxyribonuclease activity (GO:0004520) |
| Related biological processes | DNA repair, meiotic recombination, apoptosis |
What Is GO:0032079?
GO:0032079 is defined as any process that activates or increases the frequency, rate or extent of endodeoxyribonuclease activity, the hydrolysis of ester linkages within deoxyribonucleic acid by creating internal breaks. In other words, it covers the upstream signals, protein-protein interactions, and post-translational modifications that enhance the ability of endodeoxyribonucleases to cleave DNA internally.
Why Is positive regulation of endodeoxyribonuclease activity Important in Cell Biology?
Positive regulation of endodeoxyribonuclease activity is crucial for maintaining genomic integrity and for executing developmental programs that require DNA breakage, such as meiotic recombination and immune diversification. Its dysregulation can lead to inappropriate DNA breaks, contributing to oncogenesis and neurodegeneration. Moreover, understanding how endodeoxyribonucleases are activated is essential for designing targeted therapies that modulate DNA repair pathways in cancer.
• Ensures proper meiotic recombination by regulating RAD51 and DMC1 loading.
• Prevents DNA damage-independent recombination events that could cause aneuploidy.
• Influences chromatin remodelling and transcriptional activation through BRG1.
• Modulates sensitivity to DNA-damaging agents in cancer therapy.
• Plays a role in immune cell development via V(D)J recombination.
• Contributes to neuronal survival by regulating DNA repair in post-mitotic cells.
• Affects mitochondrial DNA maintenance and cellular metabolism.
• Can be targeted to enhance CRISPR-based genome editing efficiency.
• Serves as a biomarker for cancers with defective DNA repair.
• Provides a point of intervention for radiosensitization and chemosensitization.
What Happens During positive regulation of endodeoxyribonuclease activity?
Upstream signalling and activation
In simple terms: Signals tell the cell to turn on DNA-cutting enzymes.
Positive regulation begins with upstream signals such as DNA damage, developmental cues, or metabolic stress that activate kinases and transcription factors. For example, the FIGNL1-FIRRM complex is essential for meiotic recombination and prevents DNA damage-independent RAD51 and DMC1 loading, thereby ensuring that endodeoxyribonuclease activity is properly timed. Chromatin remodellers like BRG1 can also activate transcription of genes encoding endodeoxyribonucleases or their regulators.
Post-translational modification of endodeoxyribonucleases
In simple terms: Chemical tags are added to the enzymes to switch them on.
Endodeoxyribonucleases can be activated by phosphorylation, acetylation, ubiquitination, or SUMOylation. These modifications alter enzyme conformation, stability, or subcellular localization. For instance, posttranscriptional regulation of restriction activity in bacteria involves modulation of EcoP1I and EcoP15I endonuclease levels, illustrating that similar principles apply across kingdoms.
Protein-protein interactions and complex assembly
In simple terms: Helper proteins bind to the enzyme to boost its activity.
Positive regulators often form complexes with endodeoxyribonucleases. The FIGNL1-FIRRM complex interacts with RAD51 and DMC1 to regulate their loading onto DNA, which is critical for meiotic recombination. Similarly, chromatin remodelling complexes such as SWI/SNF (containing BRG1) can facilitate access of endodeoxyribonucleases to nucleosomal DNA.
Cofactor and metal ion availability
In simple terms: Metal ions help the enzyme cut DNA.
Many endodeoxyribonucleases require divalent metal ions (Mg2+, Mn2+) as cofactors. Positive regulation can occur through changes in intracellular metal ion concentrations or through proteins that deliver metal ions to the enzyme. For example, metabolically-targeted dCas9 expression in bacteria modulates CRISPR-associated endonuclease activity, which depends on metal ion availability.
Transcriptional and post-transcriptional control
In simple terms: The cell makes more or less of the enzyme by controlling its mRNA.
Positive regulation can also occur at the level of gene expression. Transcription factors such as Sp1 positively regulate the human alpha 1 (I) collagen promoter, and similar mechanisms may control endodeoxyribonuclease genes. Additionally, microRNAs and RNA-binding proteins can stabilize or degrade mRNAs encoding these enzymes, as seen in prolactin regulation of pim-1 expression.
Key Genes Involved in GO:0032079 positive regulation of endodeoxyribonuclease activity
The following genes and proteins are key players in the positive regulation of endodeoxyribonuclease activity, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| FIGNL1 | Forms complex with FIRRM to regulate RAD51/DMC1 loading during meiosis | Essential for meiotic recombination; knockout leads to DNA damage-independent recombination |
| FIRRM | Partners with FIGNL1 to prevent inappropriate RAD51/DMC1 loading | Critical for genome stability during meiosis |
| RAD51 | RecA-like recombinase involved in homologous recombination | Its loading is regulated by FIGNL1-FIRRM; key for DNA repair |
| DMC1 | Meiosis-specific recombinase | Regulated by FIGNL1-FIRRM; essential for meiotic recombination |
| BRG1 | ATP-dependent chromatin remodeller; activator of transcription | Acute depletion reveals primary function as transcription activator; influences DNA metabolism genes |
| Sp1 | Transcription factor | Positively regulates collagen promoter; may control endodeoxyribonuclease gene expression |
| mTORC1 | Serine/threonine kinase complex | Senses mitochondrial dysfunction; regulates metabolism and DNA repair |
| EcoP1I | Restriction endonuclease | Model for posttranscriptional regulation of endonuclease activity |
| EcoP15I | Restriction endonuclease | Model for posttranscriptional regulation of endonuclease activity |
| dCas9 | Catalytically dead Cas9 | Used for metabolic targeting; affects endonuclease expression |
| PIM1 | Proto-oncogene serine/threonine kinase | Regulated by prolactin; may influence DNA repair |
| SWI/SNF complex | Chromatin remodelling complex | Contains BRG1; regulates access to DNA |
| MRE11 | Endodeoxyribonuclease involved in DNA repair | Part of MRN complex; regulated by upstream signals |
| RAD50 | DNA repair protein | Part of MRN complex; interacts with MRE11 |
| NBS1 | DNA repair protein | Part of MRN complex; targets MRE11 to DNA damage sites |
| Caspase-activated DNase (CAD) | Endodeoxyribonuclease involved in apoptosis | Activated by caspases during programmed cell death |
| Apoptosis-inducing factor (AIF) | Endodeoxyribonuclease in apoptosis | Regulated by mitochondrial release |
| Endonuclease G | Mitochondrial endodeoxyribonuclease | Involved in apoptosis; regulated by Bcl-2 family proteins |
How Is positive regulation of endodeoxyribonuclease activity Regulated?
Positive regulation of endodeoxyribonuclease activity is controlled at multiple levels. Upstream signalling pathways such as mTORC1 sense mitochondrial dysfunction and metabolic status, thereby influencing DNA repair and endonuclease activity. Chromatin remodellers like BRG1 can activate transcription of genes encoding endodeoxyribonucleases or their regulators. Post-transcriptional mechanisms, including regulation of mRNA stability and translation, also play a role, as exemplified by prolactin regulation of pim-1 expression and posttranscriptional regulation of EcoP1I and EcoP15I restriction activity. Additionally, protein-protein interactions, such as the FIGNL1-FIRRM complex, ensure proper timing and localization of endodeoxyribonuclease activation during meiosis.
positive regulation of endodeoxyribonuclease activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| FIGNL1 | Meiotic arrest, infertility | Knockout mouse, spermatocyte culture |
| FIRRM | Meiotic recombination defects | Knockout mouse, yeast models |
| BRG1 | Cancer, neurological disorders | Conditional knockout, acute depletion |
| mTORC1 | Cancer, metabolic disorders | CRISPR knockout in cell lines |
| EcoP1I/EcoP15I | Bacterial restriction | Bacterial genetics |
Cancer
Dysregulation of endodeoxyribonuclease positive regulation can lead to genomic instability and cancer. For example, altered FIGNL1-FIRRM function may cause inappropriate recombination, contributing to tumorigenesis. mTORC1 signalling, which senses mitochondrial dysfunction, is frequently deregulated in cancer and can affect DNA repair pathways. Targeting positive regulators of endodeoxyribonucleases may sensitize cancer cells to DNA-damaging therapies.
Neurodegeneration
Neurons are post-mitotic and rely heavily on DNA repair. Impaired regulation of endodeoxyribonuclease activity could lead to accumulation of DNA damage and neuronal death, as seen in neurodegenerative disorders. Chromatin remodelling defects involving BRG1 have been linked to neurological disorders.
Developmental disorders
Proper meiotic recombination is essential for fertility. Mutations in FIGNL1 or FIRRM cause meiotic arrest and infertility due to defective RAD51/DMC1 loading. Thus, positive regulation of endodeoxyribonuclease activity is critical for germ cell development.
Immune disorders
V(D)J recombination requires endodeoxyribonuclease activity to generate antibody and T-cell receptor diversity. Defects in its regulation can cause immunodeficiency or autoimmunity.
From positive regulation of endodeoxyribonuclease activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does FIGNL1-FIRRM complex directly activate endodeoxyribonuclease? | Knockout and knock-in of FIGNL1 in mouse germ cells |
| How does BRG1 regulate endodeoxyribonuclease gene expression? | Acute depletion of BRG1 in ES cells |
| What is the role of mTORC1 in sensing mitochondrial dysfunction? | Genome-wide CRISPR screens |
| Can dCas9 be used to modulate endonuclease expression? | Metabolically-targeted dCas9 in bacteria |
| How is EcoP1I restriction activity regulated posttranscriptionally? | Bacterial two-plasmid system |
| Does Sp1 regulate endodeoxyribonuclease promoters? | Promoter-reporter assays |
How to Study the positive regulation of endodeoxyribonuclease activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout screens | Gene essentiality and regulators | Identify positive regulators of endodeoxyribonuclease |
| RNA-seq | Transcriptional changes | Measure expression of endodeoxyribonuclease genes |
| Proteomics | Protein abundance and modifications | Detect post-translational activation |
| In vitro nuclease assay | Enzymatic activity | Directly test positive regulation |
| ChIP-seq | Protein-DNA interactions | Map binding of regulators to target genes |
| Immunofluorescence | Subcellular localization | Visualize recruitment to DNA damage |
| Co-immunoprecipitation | Protein-protein interactions | Identify regulatory complexes |
| Metabolic targeting with dCas9 | Gene expression control | Modulate endonuclease levels |
CRISPR screens
Genome-wide CRISPR screens can identify genes that positively regulate endodeoxyribonuclease activity. For example, a screen for mTORC1 signalling revealed multitiered mechanisms through which mTORC1 senses mitochondrial dysfunction. Such screens are powerful for discovering novel regulators.
Transcriptomics and proteomics
RNA-seq and proteomics can quantify changes in endodeoxyribonuclease expression and post-translational modifications upon activation. For instance, acute depletion of BRG1 followed by RNA-seq revealed its primary function as an activator of transcription.
Enzyme activity assays
In vitro endodeoxyribonuclease assays using plasmid or oligonucleotide substrates can directly measure positive regulation. These assays are often coupled with immunodepletion or reconstitution of purified components.
Imaging and localization
Fluorescence microscopy can visualize recruitment of endodeoxyribonucleases to DNA damage sites. For example, GFP-tagged RAD51 and DMC1 were used to study their loading in the presence or absence of FIGNL1-FIRRM.
How CRISPR Can Be Used to Study GO:0032079 positive regulation of endodeoxyribonuclease activity
Knockout
CRISPR knockout of candidate positive regulators (e.g., FIGNL1, FIRRM) can abolish endodeoxyribonuclease activation, leading to meiotic arrest and DNA damage sensitivity. Knockout models are essential to establish causality.
Point Mutation
Introducing point mutations in catalytic or regulatory domains of endodeoxyribonucleases or their regulators can dissect specific functions. For example, mutations in the FIGNL1-FIRRM interface may disrupt complex formation without affecting other activities.
Knock-in
Knock-in of tagged versions (e.g., GFP, HA) allows visualization and immunoprecipitation of endodeoxyribonucleases and their regulators. This approach was used to study BRG1 dynamics.
Overexpression
Overexpression of positive regulators can enhance endodeoxyribonuclease activity, potentially increasing recombination or sensitizing cells to DNA damage. For instance, overexpression of Sp1 increased collagen promoter activity, and similar strategies can be applied to endodeoxyribonuclease regulators.
How EDITGENE Supports positive regulation of endodeoxyribonuclease activity Research
Researchers studying positive regulation of endodeoxyribonuclease activity-related genes often need to determine whether a candidate gene is causally involved in activating DNA cleavage, and to dissect the precise molecular mechanism. EDITGENE provides a comprehensive suite of CRISPR services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of endodeoxyribonuclease activity research.
Frequently Asked Questions About positive regulation of endodeoxyribonuclease activity
What is GO:0032079?
GO:0032079 is a Gene Ontology biological process term defined as any process that activates or increases the frequency, rate or extent of endodeoxyribonuclease activity, the hydrolysis of ester linkages within DNA by creating internal breaks.
What genes are involved in positive regulation of endodeoxyribonuclease activity?
Key genes include FIGNL1, FIRRM, RAD51, DMC1, BRG1, and mTORC1, among others.
How does FIGNL1-FIRRM regulate endodeoxyribonuclease activity?
The FIGNL1-FIRRM complex prevents DNA damage-independent RAD51 and DMC1 loading, ensuring proper meiotic recombination.
What diseases are associated with dysregulation of endodeoxyribonuclease activity?
Dysregulation is linked to cancer, neurodegeneration, infertility, and immune disorders.
What methods are used to study positive regulation of endodeoxyribonuclease activity?
CRISPR screens, RNA-seq, proteomics, in vitro nuclease assays, and imaging are commonly used.
Can CRISPR be used to model positive regulation of endodeoxyribonuclease activity?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are powerful tools to dissect the regulatory network.
What is the role of BRG1 in endodeoxyribonuclease regulation?
BRG1 is a chromatin remodeller that acts as an activator of transcription and can influence expression of DNA metabolism genes.
How does mTORC1 sense mitochondrial dysfunction to regulate endodeoxyribonuclease activity?
Genome-wide CRISPR screens revealed multitiered mechanisms through which mTORC1 senses mitochondrial dysfunction, impacting DNA repair pathways.
What are the synonyms for GO:0032079?
Synonyms include activation of endodeoxyribonuclease activity, endodeoxyribonuclease activator, stimulation of endodeoxyribonuclease activity, up regulation of endodeoxyribonuclease activity, up-regulation of endodeoxyribonuclease activity, and upregulation of endodeoxyribonuclease activity.
Why is positive regulation of endodeoxyribonuclease activity important for genome stability?
It ensures that DNA breaks occur at the right time and place, preventing inappropriate recombination and maintaining genomic integrity.
Conclusion
GO:0032079, positive regulation of endodeoxyribonuclease activity, is a critical biological process that governs when and where DNA-cleaving enzymes are activated. Its proper regulation is essential for meiosis, DNA repair, and development, while its dysregulation contributes to cancer, neurodegeneration, and infertility. By leveraging CRISPR-based models and high-throughput screening, researchers can uncover the intricate regulatory networks controlling endodeoxyribonuclease activity, paving the way for novel therapeutic interventions.
References
- 1. Zainu A et al.. 2024. FIGNL1-FIRRM is essential for meiotic recombination and prevents DNA damage-independent RAD51 and DMC1 loading.. Nat Commun 15(1):7015 PMID: 39147779
- 2. Condon KJ et al.. 2021. Genome-wide CRISPR screens reveal multitiered mechanisms through which mTORC1 senses mitochondrial dysfunction.. Proc Natl Acad Sci U S A 118(4) PMID: 33483422
- 4. Li L et al.. 1995. Positive regulation of human alpha 1 (I) collagen promoter activity by transcription factor Sp1.. Gene 164(2):229-34 PMID: 7590335
- 5. Pellegrino GM et al.. 2023. Metabolically-targeted dCas9 expression in bacteria.. Nucleic Acids Res 51(2):982-996 PMID: 36629257
- 6. Ren G et al.. 2024. Acute depletion of BRG1 reveals its primary function as an activator of transcription.. Nat Commun 15(1):4561 PMID: 38811575
- 7. Borg KE et al.. 1999. Prolactin regulation of pim-1 expression: positive and negative promoter elements.. Endocrinology 140(12):5659-68 PMID: 10579330
- 8. Redaschi N et al.. 1996. Posttranscriptional regulation of EcoP1I and EcoP15I restriction activity.. J Mol Biol 257(4):790-803 PMID: 8636982
